PMID: 26881725DOI: 10.1021/acs.jmedchem.5b01769Feb 18, 2016Paper
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi
Journal of Medicinal Chemistry
Kazuhiko YamasakiHitoshi Sakashita
Abstract
Although NMR in fragment-based drug discovery is utilized almost exclusively to evaluate physical binding between molecules, it should be also a powerful tool for biochemical assay, evaluating inhibitory effect of compounds on enzymatic activity. Time-dependent spectral change in real-time monitoring or inhibitor concentration-dependent spectral change after constant-time reaction was processed by factor analysis, by which reaction rate or IC50 value was obtained. Applications to spermidine synthase of Trypanosoma cruzi, which causes Chagas disease, are described.
References
Oct 26, 1977·Journal of the American Chemical Society·J W CornforthJ P Glusker
Nov 1, 1992·Journal of Biomolecular NMR·M PiottoV Sklenár
Jan 15, 1991·Biochemical Pharmacology·A ShirahataK Samejima
Aug 1, 1988·Chemical & Pharmaceutical Bulletin·A ShirahataK Samejima
Dec 17, 1985·Biochemical and Biophysical Research Communications·J WagnerC Danzin
Dec 1, 1973·Biochemical Pharmacology·Y Cheng, W H Prusoff
Apr 15, 1980·Archives of Biochemistry and Biophysics·K Samejima, Y Nakazawa
Nov 29, 1996·Science·S B ShukerS W Fesik
Jun 21, 2001·Journal of the American Chemical Society·M Mayer, B Meyer
Feb 5, 2003·Drug Discovery Today·Gilbert M Rishton
Jul 5, 2003·Biological & Pharmaceutical Bulletin·Hideki DejimaKeijiro Samejima
Nov 20, 2003·Journal of the American Chemical Society·Claudio DalvitMarina Veronesi
Jun 25, 2004·Journal of Medicinal Chemistry·Daniel A ErlansonTom O'Brien
Jun 26, 2007·Biochemistry·Hong WuAlexander N Plotnikov
Sep 8, 2007·Journal of Molecular Biology·Veronica Tamu DufeSalam Al-Karadaghi
Oct 22, 2009·Nucleic Acids Research·Martin AslettHaiming Wang
May 21, 2013·Journal of Biomolecular NMR·Mary J HarnerStephen W Fesik
Sep 14, 2013·Analytical Chemistry·Kazuhiko YamasakiTakamitsu Kohzuma
Sep 4, 2015·Acta Crystallographica. Section D, Biological Crystallography·Yasushi AmanoHitoshi Sakashita
❮ Previous
Next ❯
Citations
Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases
May 27, 2017·Chemical Biology & Drug Design·Juliana da Fonseca Rezende E MelloGustavo Henrique Goulart Trossini
Oct 20, 2018·The Journal of Biological Chemistry·Margaret A Phillips
Sep 13, 2019·Expert Opinion on Drug Discovery·Miaomiao Liu, Ronald J Quinn
Sep 28, 2018·Current Medicinal Chemistry·Alan TaleviMarcelo Comini
Apr 9, 2021·Journal of Biochemistry·Kazuhiko YamasakiHiroto Suematsu
May 18, 2018·Journal of Medicinal Chemistry·Osamu TaniKazuhiko Yamasaki
❮ Previous
Next ❯
Related Concepts
Related Feeds
Related Papers
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
Hiroyuki Hanzawa, Takeshi Takizawa
The Analyst
Jochen KlagesHorst Kessler
Arquivos brasileiros de cardiologia
G Bellotti, F Pileggi
Journal of Medicinal Chemistry
Daniel A ErlansonTom O'Brien
Journal of Computer-aided Molecular Design
Wendy A Warr